Article

jdsupra.com on 2023-12-14 00:06

Janssen and Samsung Bioepis Settle STELARA (Ustekinumab) Litigation

Samsung Bioepis recently reported that it has signed a settlement and license agreement with Johnson & Johnson (“J&J”) in the United States ...

United States

Related news

Formycon/Fresenius Kabi and Samsung Bioepis Settlements with J&J and Janssen Biotech regarding Ustekinumab jdsupra.com
United States
Celltrion Stelara (Ustekinumab) Settlement With J&J jdsupra.com
United States , The Settlement
Immunex and Samsung Bioepis Seek to Stay Etanercept Biosimilar Litigation jdsupra.com
California , United States , Switzerland
New BPCIA Litigation: Janssen v. Samsung Bioepis (D.N.J.)jdsupra.com
New Jersey
Ustekinumab Antitrust Litigation jdsupra.com
Sherman
Biocon Settles with Janssen, Securing U.S. Market Entry Date for Ustekinumab Biosimilar jdsupra.com
United States
Deal Watch: Samsung Bioepis and Takeda Enter into Partnership jdsupra.com
EMA Reviews Samsung Bioepis’ Lucentis Biosimilar For Eye Diseases jdsupra.com
Australia , Japan , Europe , Canada , United States
Samsung Bioepis Files IPR Petition Challenging Regeneron Aflibercept Patent jdsupra.com
Chengdu
Alvotech Announces More Settlements and Expected Launch Dates Regarding Biosimilar to STELARA (ustekinumab), AVT04 jdsupra.com
United States , Japan , Canada
Final Judgment and Order of Permanent Injunction Entered in Immunex v. Samsung Bioepis Etanercept Biosimilar Litigation jdsupra.com
United States , New Jersey
Alvotech and Teva’s Selarsdi™ (ustekinumab-aekn), Biosimilar to Stelara® Approved by FDA jdsupra.com
Samsung Bioepis Presents New Biosimilars Data at EULAR 2016 jdsupra.com
Amgen and Sandoz Settle Denosumab BPCIA Litigation jdsupra.com
United States , New Jersey
Alvotech and Teva Announce Acceptance of BLA for AVT04, a Proposed Biosimilar to STELARA (ustekinumab)jdsupra.com
Preliminary Injunction Issued Against Samsung Bioepis in Aflibercept BPCIA Litigation jdsupra.com
Samsung Bioepis Announces Approval of Citrate-Free, High-Concentration Adalimumab Biosimilar in Canada jdsupra.com
Canada
Biogen and Samsung Bioepis launch BYOOVIZ (ranibizumab-nuna)jdsupra.com
United States
FDA Accepts Review of Samsung Bioepis and Biogen’s Ranibizumab Biosimilar jdsupra.com
Australia , Japan , Europe , Canada , United States
Updates on Aflibercept Biosimilar Approvals and BPCIA Litigation jdsupra.com
West Virginia , California , Central District